Proceedings of the 4th International Symposium on Health Research (ISHR 2019)

Curcumin as an Alternative Medicine for Terminal Stage Endometrial Cancer Patient (Case Report)

Authors
I.B.G. Fajar Manuaba
Corresponding Author
I.B.G. Fajar Manuaba
Available Online 22 February 2020.
DOI
10.2991/ahsr.k.200215.022How to use a DOI?
Keywords
Curcumin, endometrial cancer
Abstract

Curcumin has historically been used in anti-cancer therapies. However, the anti-metastatic effect and molecular mechanism of curcumin in endometrial carcinoma (EC) are still poorly understood. In this case, the patient administrated with 1,000 mg curcumin as an alternative medicine after completed operation and chemotherapy. To evaluate the effect of Curcumin as an alternative medicine after completed operation and chemotherapy of endometrial carcinoma. A 62 years old woman has been diagnosis with stage IV B endometrial cancer and was treated with Radical Hysterectomy and Omectectomy on April 18th 2016. Patology result was endometrial carcinoma type endometrioid. After the operation, Paxus Carboplatin chemotherapy had been given for six series and finished on August 2016. In our experience, the life expectancy after completed surgical procedure and chemotherapy is not more than one year. This condition could make patient fell hopeless and ask for alternative treatment. In this case, the woman was administrated with 1,000 mg curcumin everyday which was started before the operation and continued after completed chemoterapy. During our observation, we found no side effect of using curcumin as an alternative medicine. She has free of any complaints in the year 2017. The relapse of endometrial cancer was found in July 2018. During 2018, we performed secondary debulking and continued with six series of Paxus Carboplatin chemotherapy. During 2018 until she died on January 28th 2019, her condition got worse. In this case, we have an experience using curcumin as an alternative medicine for terminal stage endometrial cancer patient which may increase the life expectancy for more than one year. Eventhougth we could not cure the patient, but we have an opportunity to prolong her life expectancy for more than 2 years with one year free of any complains. We have to conduct more research in curcumin as an alternative medicine for endometrial cancer patient to get more data of the efficacy of curcumin.

Copyright
© 2020, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

Volume Title
Proceedings of the 4th International Symposium on Health Research (ISHR 2019)
Series
Advances in Health Sciences Research
Publication Date
22 February 2020
ISBN
978-94-6252-911-3
ISSN
2468-5739
DOI
10.2991/ahsr.k.200215.022How to use a DOI?
Copyright
© 2020, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - CONF
AU  - I.B.G. Fajar Manuaba
PY  - 2020
DA  - 2020/02/22
TI  - Curcumin as an Alternative Medicine for Terminal Stage Endometrial Cancer Patient (Case Report)
BT  - Proceedings of the 4th International Symposium on Health Research (ISHR 2019)
PB  - Atlantis Press
SP  - 113
EP  - 116
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.200215.022
DO  - 10.2991/ahsr.k.200215.022
ID  - FajarManuaba2020
ER  -